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xpansion and fate choice of pluripotent stem cells
along the neuroectodermal lineage is regulated by a
number of signals, including EGF, retinoic acid, and
NGF, which also control the proliferation and differentiation
of central nervous system (CNS) and peripheral nervous
system (PNS) neural progenitor cells. We report here the
identiﬁcation of a novel gene, 
 
REN
 
, upregulated by neuro-
genic signals (retinoic acid, EGF, and NGF) in pluripotent
embryonal stem (ES) cells and neural progenitor cell lines
in association with neurotypic differentiation. Consistent
with a role in neural promotion, 
 
REN
 
 overexpression induced
neuronal differentiation as well as growth arrest and
E
 
p27
 
Kip1
 
 expression in CNS and PNS neural progenitor cell
lines, and its inhibition impaired retinoic acid induction of
neurogenin-1 and NeuroD expression. 
 
REN
 
 expression is
developmentally regulated, initially detected in the neural
fold epithelium of the mouse embryo during gastrulation,
and subsequently throughout the ventral neural tube, the
outer layer of the ventricular encephalic neuroepithelium
and in neural crest derivatives including dorsal root ganglia.
We propose that 
 
REN
 
 represents a novel component of the
neurogenic signaling cascade induced by retinoic acid,
EGF, and NGF, and is both a marker and a regulator of
neuronal differentiation.
 
Introduction
 
A critical role for EGF receptor (EGF-R)* signaling has been
described in the differentiation of pluripotent stem cells. In-
deed, EGF-R is expressed in early-stage embryo (Wiley et al.,
1992), and EGF regulates the expansion and/or differentia-
tion in vitro and in vivo of specific cell lineages generated
from pluripotent embryonal stem (ES) cells (Threadgill et al.,
1995; Wu and Adamson, 1996; Schuldiner et al., 2000).
More specifically, EGF regulates neural cell fate choice and
expansion of pluripotent murine P19 embryonal cells, and of
both human and murine ES cells in vitro and in vivo (Wu and
Adamson, 1993; Guan et al., 2001; Reubinoff et al., 2001).
The neurogenic activity of EGF also affects central nervous
system (CNS) and peripheral nervous system
 
 
 
(PNS) neural
stem cells. EGF, in combination with FGF, is required to pro-
mote differentiation within the neural lineage and may allow
the emergence of primitive neural stem cells (for review see
Vaccarino et al., 2001). In vivo administration of EGF and the
EGF-R ligand TGF
 
 
 
 induce the expansion and differentiation
of CNS neural progenitor cells (Craig et al., 1996; Fallon et al.,
2000). Likewise, EGF sustains the self-renewal of cultured
adult and embryonic neural stem cells before further lineage
selection, dependent on additional regulatory factors (Lillien
and Raphael, 2000; Represa et al., 2001; Gritti et al., 2002). In
addition to behaving as a mitogen for immature neuroblasts,
EGF also acts as a survival or differentiation-inducing factor for
neurons (Morrison et al., 1987; Cattaneo and Pelicci, 1998).
EGF-R signaling influences neural crest cell behavior by medi-
ating TGF
 
 
 
-promoted neurite outgrowth and the survival of
dorsal root ganglia (Chalazonitis et al., 1992). EGF also
promotes proliferation and neural rather than myogenic lineage
determination of neural crest–derived TC-1S cells (Screpanti et
al., 1995; Vacca et al., 1999; Giannini et al., 2001), stimulates
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the proliferation of PC12 pheochromocytoma and neuroblas-
toma cells, and promotes their terminal differentiation (Naka-
fuku and Kaziro, 1993; Janet et al., 1995; Mark et al., 1995).
How a single growth factor receptor pathway may elicit such
wide ranging effects is still an open question. A number of re-
ports suggest that this might occur via cooperation with differ-
entiation specifying coregulatory signals. Several transduction
pathways have been reported to functionally interact with
EGF-generated signals. Indeed, the requirement of an activated
EGF-R signaling for retinoic acid (RA)-induced neuronal dif-
ferentiation of P19 cells, has been shown (Wu and Adamson,
1993). Finally, EGF and NGF also share common down-
stream signals that lead to PC12 cell differentiation (Marshall,
1995; Cattaneo and Pelicci, 1998;
 
 
 
Klesse et al., 1999).
Therefore, EGF-induced promotion of a neural cell fate
by progenitor cell populations would appear to be conserved
between pluripotent ES cells and progenitors of CNS and
PNS origin. However, the EGF-responsive genes that medi-
ate these responses and their relationships with coregulatory
signals, remain to be identified. To this end we have investi-
gated genes differentially regulated during EGF-induced
neurogenic fate selection and report the identification of a
novel EGF-responsive gene, 
 
REN
 
, upregulated by several
neurogenic signals (RA and NGF), that exhibits develop-
mentally regulated neural tissue specific expression in the
embryo and promotes neuronal differentiation of undiffer-
entiated cells while inducing growth arrest. Our data suggest
that 
 
REN
 
 is a novel target involved in RA, EGF, and NGF
downstream neurogenic signals and may terminate growth-
enhancing EGF-derived signals, permitting progenitor cells
to undergo growth arrest and neuronal cell differentiation.
 
Results
 
REN
 
 is upregulated by multiple neurogenic signals
 
In order to identify differentiation associated genes in addi-
tion to those related to enhanced proliferation, we analyzed
the pattern of gene expression induced during EGF-triggered
neurotypic differentiation of neural crest–derived TC-1S
cells, by mRNA fingerprinting differential display (Giannini
et al., 2001)
 
.
 
 EGF-regulated genes were compared with pre-
viously described genes or EST sequences upregulated during
RA-induced ES neuronal differentiation. Among the panel of
EGF-regulated genes, we describe in this report 
 
REN
 
 cDNA
(see below), which corresponds to the EST sequence
AW244266, which is significantly upregulated during RA-
induced neuronal differentiation of ES cells (Bain et al.,
2000). To correlate gene expression profiles obtained by
mRNA fingerprinting with the neural differentiation process,
we also screened a number of cell lines whose neural differen-
tiation was enhanced by multiple neurogenic signals. In par-
ticular, we investigated P19 embryonic cells and embryonal
striatal ST14A or pheocromocytoma PC12 and neuroblas-
toma N2a cells as representative of either CNS or PNS/neu-
ral crest–derived neural progenitors, respectively (Mark et al.,
1995; Prinetti et al., 1997; Cattaneo and Conti, 1998).
RA-induced neuronal differentiation of P19 cells (Boud-
jelal et al., 1997) was associated with enhanced levels of 3.0
Kb 
 
REN
 
 mRNA (Fig. 1 A). Likewise, the neurogenic activ-
ity of EGF was also associated with enhanced 
 
REN
 
 expres-
sion. EGF increased 
 
REN
 
 mRNA levels in ST14A cells in as-
sociation with the expression of the neuronal marker MAP2
and extension of neurite-like cell processes (Fig. 1 B). Fur-
thermore, 
 
REN
 
 expression was also upregulated in both TC-
1S and PC-12 cells (Fig. 1 E), during EGF-induced neu-
ronal differentiation (Nakafuku and Kaziro, 1993; Screpanti
et al., 1995).
NGF shares with EGF the capacity to promote neuronal
differentiation of TC-1S and PC-12 cells (Screpanti et al.,
1992; Klesse et al., 1999) and increased 
 
REN
 
 mRNA levels
in both cell lines (Fig. 1 D). RA and serum starvation also
upregulated 
 
REN
 
 mRNA levels in N2a cells (Fig. 1 C) in as-
sociation with neuronal differentiation (Prinetti et al., 1997;
Franklin et al., 1999).
Figure 1. REN is upregulated by multiple 
neural differentiation signals. Northern 
blot analysis of REN mRNA in P19 (A), 
ST14A (B), N2a (C), and TC1S and PC12 
(D and E) cells. Hybridization with REN 
(top) and the ubiquitous GADPH (bottom) 
are indicated. P19 cells aggregates were 
treated with 1  M RA for 4 d and, after 
plating, cultured in the absence of RA 
for further 4 d. ST14A cells were treated 
for 1–24 h with EGF (10 ng/ml) (B, top). 
(B, bottom) Phase contrast microscopy 
(left) and immunofluorescence coimmuno-
staining of cells with either anti-MAP2 
antibody (red) or Hoechst (blue, right), 
3 d after culturing in the absence (con-
trol) or in the presence of EGF treatment 
(EGF). N2a cells were cultured either in 
0.2% FCS for 1–3 d or in the presence of 
2% FCS plus 20  M RA for 2 d (RA). 
TC-1S and PC12 cells were treated for 
1–24 h or 1–5 d, respectively, with EGF 
(10 ng/ml, E) or with NGF (50 ng/ml, D). 
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Therefore, upregulation of 
 
REN
 
 gene expression would
appear to be a conserved feature of neuronal differentiation
of pluripotent ES cells, CNS and PNS progenitors, thus rep-
resenting a marker of neuronal differentiation triggered by a
variety of neurogenic signals.
 
Cloning of full-length 
 
REN
 
 cDNA
 
The partial (260 bp) cDNA clone that we refer to as 
 
REN
 
(for induced by retinoic acid, EGF, and NGF) identified as
described above, was used to screen a mouse embryo (E7)
cDNA library, and resulted in the isolation of a cDNA,
comprised of 2,688 bp before a poly(A) tail (Fig. 2 A). Se-
quence analysis revealed an ORF of 232 amino acids (Fig. 2
A) with a typical AATAAA polyadenylation consensus signal
present 14 bp 5
 
 
 
 to the poly(A) tail and 1,227 bp down-
stream of a stop codon (Fig. 2 A). BLAST search revealed no
homology with any previously described murine or human
gene of known function. However, 
 
REN
 
 shares 85% nucle-
otide and 88% amino acid identity with a putative human
cDNA ORF, detected in both GenBank and EST databases
(EMBL/GenBank/DDBJ accession no. AK056227), that is
upregulated during neuronal differentiation of NTera2
pluripotent teratocarcinoma cells.
A protein similarity search revealed that REN amino acids
21 to 72 encode a BTB/POZ motif (Bardwell and Treis-
man, 1994) (Fig. 2 A), with no other similarities to known
proteins detected. Sites for possible posttranslational modifi-
cation include putative N-myristoylation and phosphoryla-
tion sites for PKC and casein kinase 2 (Fig. 2 A). The REN
amino acid sequence is consistent with a soluble protein.
The 
 
REN
 
 mRNA product exhibits an approximate molecu-
lar mass of 26 kD, similar to the calculated mass of the pro-
tein and to that of the protein upregulated by NGF in PC12
cells or extracted from cells transfected with either 
 
REN
 
 or
myc epitope–tagged 
 
REN
 
 expression vectors, detected using
either anti-REN polyclonal or anti-myc monoclonal anti-
bodies (Fig. 2 B).
 
Developmentally regulated expression of 
 
REN
 
 in the 
mouse nervous system
 
Northern blot analysis of adult mouse tissues did not reveal
significant levels of 
 
REN
 
 mRNA, with the exception of low
levels in lung tissue (Fig. 3 A). 
 
REN
 
 mRNA expression was
detected in E7 embryo, with lower levels observed at subse-
quent stages (E11–E17) (Fig. 3 B, left). A more detailed
Figure 2. Sequence and expressoin of REN cDNA and protein. 
(A) Nucleotide and predicted amino acid sequence of mouse REN 
cDNA. The first and last codons of the ORF are boxed and the 
putative polyadenylation signal is in bold-face type and underlined. 
Putative casein kinase 2 (dotted underline), protein kinase C (under-
line), and N-myristoylation (thick underline) sites and BTB/POZ mo-
tif (boxed) are shown. These sequence data are available from 
at EMBL/GenBank/DDBJ accession no. AF465352. (B) Western blot 
analysis of REN protein in cell lysates from COS7 mock-transfected 
cells (control), transiently transfected with pCXN2-REN-myc encoding 
myc epitope-tagged REN protein (RENTag) or with pCXN2-REN 
encoding wild- type REN (REN) (arrows). Immunoblotting was 
performed with either anti-REN (RENAb) polyclonal or anti-myc 
(TagAb) monoclonal antibodies. (C) Western blot analysis of REN 
protein in cell lysates from PC12 cells treated for the indicated times 
with NGF, revealed by anti-REN antibody.  -Tubulin staining is also 
shown, as a loading control.
Figure 3. REN mRNA levels in adult murine tissues and during 
embryo development. Northern blot analysis of RNA isolated from 
adult mouse tissues (A) or from E7 to E17 whole embryos (CLONTECH 
Laboratories, Inc.; B, left), hybridized with REN cDNA. RT-PCR 
analysis (B, right) of REN RNA isolated from embryos at E7.5–E11.5. 
RT-PCR analysis of coamplified GAPDH is also shown. 
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analysis of 
 
REN
 
 transcripts, performed by semiquantitative
RT-PCR, revealed a peak of gene expression at E8.5, with
decreasing levels thereafter (Fig. 3 B, right).
The developmental pattern of 
 
REN
 
 expression was also in-
vestigated by in situ hybridization using embryos of ages
E7.5–E16.5. At E7.5, 
 
REN
 
 transcript was detected in the ec-
todermal neural folds, the primitive streak and the ectopla-
cental cone (Fig. 4, A and B). Subsequently (E8.25–E10.5),
a 
 
REN
 
 hybridization signal was detected along the entire
neural tube, in the first rhombomere and in the optic and
otic vesicles, although 
 
REN
 
 was also expressed in the maxil-
lary and mandibular component of first branchial arch, in
the somites and in the limb buds (Fig. 4, C–F).
Sections of E8.25–E10.5 embryos revealed 
 
REN
 
 expres-
sion in the neuroepithelium of the cephalic neural folds and
of the neural tube, where 
 
REN
 
 was strongly expressed in the
middle and ventral region in layers external to the lumen
(Fig. 4, G–K and M). 
 
REN
 
 expression within the neural
tube was confirmed by RT-PCR analysis of mRNA isolated
from primary neural tube cell cultures derived from E9.5
neural tube explants (Fig. 4 J).
 
REN
 
 expression was also observed in the neural crest–
derived spinal primordia, that give rise to the sensory cells of
dorsal root ganglia (Fig. 4 K), in the optic stalk and vescicle
(Fig. 4, H and M) and in the nasal process (Fig. 4 M). At
stage E16.5, 
 
REN
 
 displayed a more restricted pattern of tis-
sue expression (Fig. 4 N), confirmed by a decreased level of
mRNA detected by RT-PCR and Northern blot analysis
(Fig. 3 B). This would suggest that 
 
REN
 
 is regulated during
progressive neural development.
The ability of 
 
REN
 
 to be upregulated by signals inducing
neuronal differentiation (Fig. 1) suggests that its expression
pattern might be restricted as neuronal progenitors undergo
differentiation. Therefore, in order to investigate 
 
REN
 
 ex-
pression in actively proliferating versus differentiating neural
regions, embryo sections at E12.5–E16.5 stages were exam-
ined. At these stages neural cell proliferation occurs in the
ventricular zone lining the ventricular lumen of the cortex
(Conti et al., 1997). Conversely, differentiation follows a
gradient of neurogenesis in which postmitotic cells migrate
away from the lumen towards the cortical plate and subse-
quently mature (Bayer and Altman, 1991; Zhong et al.,
1997). 
 
REN
 
 expression was barely detectable in the ventricu-
lar zone lining the lumen, whereas a strong signal was de-
tected in outer layers of the cortical plate (Fig. 4 O) contain-
ing newly differentiated neural cells (Bayer and Altman,
1991; Conti et al., 1997; Zhong et al., 1997). A similar pat-
tern was detected in the mesencephalic and diencephalic re-
Figure 4. REN expression in mouse embryo 
tissues during development. Whole-mount in situ 
hybridization at E7.5 (A), E8 (B), E8.25 (C), E9 
(D and E) and E9.5 (F) reveals expression in the 
developing neural folds (A, white arrowhead in;
B and C, black arrowhead), along the neural tube 
(D and E, black arrowhead), in the primitive streak 
(A, arrow; C, asterisk), in the ectoplacental cone 
(B, arrow), in newly forming somites and in the first 
rhombomere (C, arrow). At later stage (F), expression 
is restricted to the ventro-medial region of the neural 
tube (arrowhead), somites, optic and otic vesicles, 
the regions of the first branchial arch, the olfactory 
placode and developing limb buds (asterisk). 
Bright-field views of sections from whole mount 
(G–I) and postembedded in situ radioactive hybrid-
izations (K–P) are also shown. Transverse sections 
confirmed expression in the cephalic neural folds 
(prospective forebrain; G, black arrowhead; 
E8.25), in the neuroepithelium of prospective hind 
brain (G, white arrowhead) and more caudally 
in the ventro-medial region of the neural tube 
(I, arrowhead; stage E8.25; K, arrow; stage E10.5). 
Coronal (H, stage E9.5) and sagittal (M, stage 
E10.5) sections show REN expression in the 
neuroepithelium of the fourth ventricle and of the 
diencephalon (H, asterisks) of the rhomboencephalic 
(Rh), mesencephalic (Mes), and telencephalic (Te) 
vesicles (M, arrowhead), in the olfactory placode 
including the epithelium lining the olfactory pit 
(M) and in the optic vesicle and stalk (H, white 
arrowhead; M, arrow). At later stages, REN expres-
sion characterizes more defined territories within 
the outer neuropeithelium layers of the midbrain 
and of the ventricular zone (VZ) of the cortical 
plate (L at stage E12.5; N; O, arrowhead; at stage E16.5). Some low and diffuse REN staining is also observed in the whole brain area (N). In 
the E16.5 embryo, outside of the brain REN expression was detected in dorsal root ganglia (N; P, arrowhead), preceded by expression in neural 
crest-derived spinal primordia (K, arrowhead). REN is also expressed in the trigeminal ganglion (O, asterisk) and in mesenchime of the maxillary 
component of the first branchial arch containing trigeminal neural crest tissue (H, black arrowhead). (J) RT-PCR analysis of REN expression in 
primary cultures of neural cells explanted from E9.5 embryonal neural tubes, cultured for 24 h (lane 1) and in differentiated N2a cells (lane 3), 
whereas no expression is detected in thymocytes isolated from newborn mice (lane 2). 
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gions at the earlier E12.5 developmental stage (Fig. 4 L).
Lower hybridization signals were observed in areas outside
of the ventricular layers of E16.5 brain (Fig 4 N). No hy-
bridization was detected in E16.5 embryo outside of the
brain, with the exception of dorsal root ganglia and trigemi-
nal ganglion of neural crest origin (Fig. 4, P and O).
These results suggest that 
 
REN
 
 expression is developmen-
tally regulated, being expressed initially by neuroectodermal
cells, later in neural crest derivatives, in the ventral region of
the spinal cord and in the ventricular epithelium of the
cephalic neural tube restricted to differentiating (outer)
rather than proliferating (inner) cells of the cortical ventricu-
lar zone.
 
Enforced expression of REN slows the proliferative rate 
and induces p27
 
Kip1
 
 upregulation
 
During neurogenesis, neuronal differentiation is preceded
by withdrawal from the cell cycle (Farah et al., 2000). The
specific pattern of 
 
REN
 
 expression in regions containing dif-
ferentiating neural progenitors at late embryonal CNS stages
(Fig. 4 O), led us to investigate whether REN expression
could regulate proliferation while permitting neuronal dif-
ferentation.
For this purpose, P19 cells were transfected with either
empty expression vector (pCXN2) or 
 
REN
 
 cDNA cloned
into pCXN2. Stable REN
 
 
 
 transfectants were selected by re-
sistance to geneticin. No clones expressing REN protein
were isolated after long term culture, suggesting that en-
forced REN expression interferes with growth and/or sur-
vival. REN control of cell growth was confirmed by bro-
modeoxyuridine (BrdU) uptake after enforced transient myc
epitope–tagged REN expression in P19 cells, which induced
a significant decrease in BrdU incorporation, when com-
pared with GFP-transfected controls (Fig. 5 A). Similar
growth inhibitory activity of REN was observed in ST14A
and N2a cells, with a significant decrease of BrdU incorpo-
ration observed after REN transfection compared with GFP-
transfected controls (Fig. 5 A).
To further characterize the growth arrest response to
REN, the expression of the cyclin-dependent kinase inhibi-
tor p27
 
Kip1
 
 was examined in 
 
REN
 
-transfected N2a cells in
which a significant increase of p27
 
Kip1
 
 levels was detected by
Western blot (Fig. 5 C). This was confirmed by immunoflu-
orescence studies in which GFP-transfected controls ex-
pressed barely detectable levels of p27
 
Kip1
 
 (5% of GFP
 
 
 
 cells
coexpressed p27
Kip1), whereas 36% of REN-transfected cells
coexpressed significantly higher levels of p27
Kip1 (Fig. 5, B
and D). Likewise, a significantly higher number of REN
transfected ST14A and P19 cells coexpressed p27
Kip1 when
compared with GFP-transfected controls (Fig. 5, B and D).
These results suggest that REN regulates cell proliferation in
several neuronal cell precursors leading to the triggering of
cell growth inhibitory signals.
Abrogation of REN expression prevents RA-induced 
enhancement of neurogenin1 and NeuroD expression 
in P19 cells
The specific neuroectodermal pattern of REN expression in
the embryo, its association with neuronal differentiation in
vivo and in vitro and its capacity to regulate cell prolifera-
tion, led us to investigate the potential role of REN in the
regulation of molecular events implicated in neural develop-
ment. Several genes are activated during RA-induced neu-
ronal differentiation of P19 cells, including neurogenic
bHLH transcription factors such as Mash1, neurogenin
(ngn)1, and NeuroD, which promote mammalian neuronal
determination and differentiation (Johnson et al., 1992;
Boudjelal et al., 1997; Massari and Murre, 2000). The en-
forced expression of NeuroD, ngn1, or Mash1 initiates cell
cycle withdrawal by increasing p27
Kip1 levels and converts
undifferentiated P19 embryonal cells into neurons (Farah et
al., 2000).
In order to investigate the involvement of REN in the reg-
ulation of neurogenic bHLH expression in differentiating
P19 cells, the effect of inhibiting REN expression was stud-
Figure 5. REN induces cell growth arrest. (A) Cell growth arrest in 
P19, N2a, and ST14A cells transfected with expression vector 
pCXN2-REN-myc or with GFP expression vector. BrdU was added 
24 h after transfection and detected after 2–24 h of incorporation. 
The percentage of BrdU incorporating cells in the REN
  or in the 
GFP
  population, was determined by coimmunostaining with 
anti-myc epitope and anti-BrdU antibodies or with anti-GFP and 
anti-BrdU antibodies and immunofluorescence microscopy. Average 
(  SEM) percentages of BrdU positive cells from three independent 
experiments performed in triplicate are shown. (B) Expression of 
p27
Kip1 in control (GFP-transfected cells, GFP) and REN cDNA-
transfected cells (REN) 48 h after transfection into P19, N2a, and 
ST14A cells. The percentage of p27
Kip1 positive cells in the REN
  
and in the GFP
  population, was determined by coimmunostaining 
with anti-myc epitope or anti-GFP antibodies and by immunofluo-
rescence microscopy. Average (  SEM) percentages of p27
Kip1 positive 
cells from three independent experiments performed in triplicate are 
shown. (C) Western blot analysis of p27
Kip1 and  -tubulin expression 
in control (GFP-transfected, GFP) and REN cDNA-transfected N2a 
cells (REN), 48 h after transfection. (D) Exogenous expression of 
REN enhances p27
Kip1 expression in N2a and ST14A cells. Confocal 
microscopy of coimmunostaining of p27
Kip1 (red) and either myc 
epitope (green, REN) or GFP (green, GFP), in either GFP- (GFP) or 
REN-transfected (REN) cells, 48 h after transfection.736 The Journal of Cell Biology | Volume 158, Number 4, 2002
ied using antisense RNA technology. P19 cells were trans-
fected either with empty expression vector pCXN2 (P19-
pCXN2 control cells) or with REN cDNA cloned into
pCXN2 in antisense orientation (P19-REN-AS), and several
individual stably transfected clones and polyclonal popula-
tions were selected by neomycin resistance.
Low levels of REN protein were detected in undifferenti-
ated P19-pCXN2 control cells (Fig. 6 A). RA treatment,
while inducing neural differentiation, increased REN pro-
tein expression above basal levels (Fig. 6 A, left). In con-
trast, several individual P19-REN-AS clones and a poly-
clonal cell population exhibited no endogenous REN
protein expression, when compared with pCXN2 transfec-
tants, either in the absence or in the presence of RA treat-
ment (Fig. 6 A, right; Table I), suggesting that both basal
and RA-enhanced REN protein production had been abro-
gated by the expression of antisense-REN. Likewise, REN–
myc fusion protein expression was significantly lower after
transfection of pCXN2-REN-myc into P19-REN-AS sta-
bly transfected cells when compared with the P19-pCXN2
controls (Table I). This confirmed that lack of REN ex-
pression in P19-REN-AS cells was not just an intrinsic
property of this selected cell population but a result of an-
tisense REN mRNA production.
RA enhanced the expression of ngn1,  NeuroD,  Mash1,
Math1, and their inhibitors Id1 and Id3 in polyclonal P19-
pCXN2 cells (Fig. 6 B), confirming previous reports (Johnson
et al., 1992; Boudjelal et al., 1997). In contrast, RA-treated
polyclonal P19-REN-AS populations exhibited a reduced in-
duction of ngn1 and NeuroD expression, whereas RA-induc-
tion of Mash1, Math1, Id1, and Id3 expression was not signifi-
cantly affected (Fig. 6 B). These data suggest that impaired
upregulation of ngn1 and NeuroD after the abrogation of REN
expression represents a specific response of P19-REN-AS cells
to RA, as RA enhanced the expression of other bHLH genes
(e.g., Mash1). Similar results were obtained with several in-
dividual P19-pCXN2 and P19-REN-AS clones (Table I).
Therefore, appropriate levels of REN are specifically required
for RA enhancement of ngn1 and NeuroD expression, sug-
gesting a role in the regulation of specific bHLH neurogenic
genes.
REN enhances the expression of neuronal markers 
in neural progenitor cells
The hypothesis that REN may promote neuronal differen-
tiation was directly addressed by transfecting either myc
epitope–tagged REN or the empty GFP-encoding vector into
cell lines representative of distinct differentiation stages or
types of progenitor cells that undergo neuronal differentiation
in response to different growth inhibitory signals (Prinetti et
al., 1997; Cattaneo and Conti, 1998; Farah et al., 2000). Un-
differentiated pluripotent P19 ES cells failed to undergo neu-
ronal differentiation (as evaluated by monitoring the expres-
sion of MAP2 or TuJ1 neuronal markers) upon transduction
of REN-myc, whereas enforced Mash1 expression enabled
cells to differentiate into mature neurons (unpublished data),
confirming a previous report (Farah et al., 2000). Therefore,
REN is not sufficient for promoting a complete neurogenic
program from an early differentiation phase.
Figure 6. Abrogation of REN expression reduces the levels of 
Neurogenin1 and NeuroD. (A) Western-blot of endogenous REN 
and protein encoded by transfected pCXN2-REN (REN) in P19 cells 
treated with RA, as described in B, and revealed using anti-REN 
antibody. (B) Northern blot analysis of RNA isolated from P19 cells 
stably transfected with either REN cDNA cloned in antisense orien-
tation into pCXN2 (P19-REN-AS) or empty vector P19-pCXN2 and 
treated with RA as described in Fig. 1 A. Blots were hybridized with 
cDNA probes for neurogenin-1, NeuroD, Math1, Mash1, Id1, and 
Id3, as indicated on each panel. Ethydium bromide staining of 
ribosomal RNA is shown as a loading control.
Table I. Differential RA-induced regulation of HLH gene expression 
in response to inhibition of REN expression
P19-pCXN2 P19-REN-AS
Pool #E3 #E5 #E10 Pool #D11 #D12 #D13
ngn1 1.0 0.95 0.98 1.1 0.20 0.35 0.25 0.15
NeuroD 1.0 0.98 1.15 0.90 0.40 0.45 0.20 0.30
Mash1 1.0 0.90 0.85 1.1 0.90 0.95 1.10 0.80
Math1 1.0 1.10 0.90 0.95 1.0 0.90 1.10 1.15
Id1 1.0 0.90 1.15 0.95 1.0 1.15 0.85 0.95
Id3 1.0 1.1 1.15 0.80 1.25 1.0 0.80 0.90
%REN+ 15% 12% 16% 13% 5% 6% 4% 5%
Relative average mRNA levels (from two experiments) of HLH gene
products in P19-REN-AS cells (polyclonal pool population and individual
#D11, #D12,  and #D13 clones), with respect to the value observed in P19-
pCXN2 (polyclonal pool population, assigned the value 1) and individual
#E3, #E5, and #E10 clonal control cells. Levels of mRNA for each gene
product were evaluated at the time of maximum induction in response
to RA treatment (as indicated in Fig. 6). The percentages of REN-positive
cells among GFP-transfected cells (%REN+) are from a representative
experiment, by evaluating myc-tag immunofluorescence in either P19-
pCXN2 and P19-REN-AS cells 24 h after cotransfection with pCXN2-
RENmyc and GFP expression vectors. Neural promotion and REN | Gallo et al. 737
In contrast, REN promoted neuronal differentiation of
neural committed progenitor cells of CNS (ST14A cells,
Fig. 7 A) or PNS (N2a cells, Fig. 7 B) origin. ST14A neu-
ral stem cells undergo postmitotic neuronal differentiation
when cultured in SFM conditioned medium, but not in
conventional growth medium (Cattaneo and Conti, 1998).
Accordingly, we observed that untransfected or GFP-trans-
fected ST14A cells exhibited morphological modifications
characterized by neurite extension and enhanced expression
of neuron-specific differentiation markers, including MAP2,
when cultured in SFM (Fig. 7 A), but not in conventional
growth medium ( 1% of GFP
 MAP2
  cells) (Fig. 7 A). In
contrast,   90% of transfected REN
  cells cultured in
growth medium exhibited MAP2 expression, with REN and
MAP2 colocalized to the cell body with additional MAP2
localization to neurite-like cell processes (Fig. 7 A).
Similarly, GFP-transfected N2a cells revealed low-level
MAP2 and TuJ1 coexpression with GFP (8 –13   2% of
GFP
 MAP2
  or GFP
 TuJ1
  cells), whereas 40   3% and
45   5% of REN
  cells exhibited high-level MAP2 or TuJ1
expression, respectively, and displayed neurite outgrowth
(Fig. 7 B). These results suggest that enforced REN expres-
sion promotes the neuron-specific protein expression in neu-
ral progenitor cells, consistent with a role for REN in neu-
ronal differentiation.
Discussion
We describe the identification and functional characterization
of a novel EGF-, NGF- and RA-responsive gene, REN, that
exhibits no significant homology with previously described
murine or human genes nor carries putative functional do-
mains observed in other classes of proteins, with the exception
of a BTB/POZ motif located at the NH2-terminal between
amino acid residues 21 and 72. Such a motif is involved in
protein–protein interactions and is typical of several CH2H2-
type transcription factors and Shaw-type potassium channels
(Bardwell and Treisman, 1994) suggesting that REN may
dimerize with other proteins, yet to be identified.
The involvement of REN in early phases of neural cell de-
velopment is suggested by its peculiar pattern of expression
during embryogenesis. In fact, REN transcripts appear in
neuroectodermal cells of neural folds and later extend to neu-
roepithelial cells throughout the neural tube and encephalic
vesicles, therefore suggesting a relationship with the early de-
velopmental neurogenetic process. Likewise, REN is specifi-
cally expressed in neural crest primordia and subsequently in
their derivatives (e.g., dorsal root ganglia and trigeminal gan-
glion). These observations are consistent with a role for REN
in the regulation of neural cell differentiation from CNS- and
neural crest/PNS-derived progenitor cells observed in vitro.
Accordingly, we also report that REN directly promotes neu-
ronal differentiation, being sufficient to trigger phenotypic
features such as neurite elongation and the expression of the
neuron specific markers (MAP2 and TuJ1), that characterize
terminal differentiation of ST14A and N2a neural progenitor
cells. However, the ability of REN to control additional cell
differentiation programs (e.g., glial) cannot be ruled out, as
suggested by the presence of REN expression in optic stalk,
known to give rise mainly to glial cells.
REN appears to be upregulated by EGF, known to en-
hance proliferation of neural stem cells. How growth signal-
Figure 7. Exogenous expression of REN enhances 
neuronal marker expression in ST14A and N2a 
neural progenitor cells. Confocal microscopy of 
combined coimmunostaining of MAP2 or TuJ1 
(red) and either myc epitope (green) or GFP (green; 
overlapping signals are yellow). (A) Untransfected 
(SFM) or GFP-transfected (GFP   SFM) ST14A cells 
grown in SFM for 7 d display a differentiated 
morphology and positive staining for MAP2. Cells 
transfected with GFP encoding expression vector 
and cultured in growth medium for 7 d, display 
GFP immunofluorescence and no staining for 
MAP2 (GFP panel). Cells transfected with myc 
epitope-tagged REN protein encoding vector and 
cultured in growth medium for 7 d, display coex-
pression of both myc epitope and MAP2 immuno-
fluorescence (REN panels). (B) N2a cells transfected 
with REN expression vector (REN) display coex-
pression of REN and either MAP2 or TuJ1, 3 d after 
transfection. In contrast, cells transfected with GFP 
encoding expression vector and cultured for 3 d, 
display GFP immunofluorescence and no staining 
for either MAP2 or TuJ1. The pictures shown are 
from a representative experiment (out of three) 
with MAP2 or TuJ1 expression scored from 150 
to 300 transfected cells examined.738 The Journal of Cell Biology | Volume 158, Number 4, 2002
enhanced REN is related to events determining neuronal dif-
ferentiation needs to be fully elucidated. However, we report
evidence indicating that this may occur via inhibition of cell
growth. Indeed, REN appears to be developmentally regu-
lated in embryonal neuroepithelial cells and its expression
correlates with the spatially defined gradient of neurogenesis
observed in the cortex, in which proliferating neuroblasts are
localized in the ventricular zone lining the lumen and, as
they subsequently exit from the cell cycle and differentiate,
migrate away from the lumen towards the cortical plate
(Bayer and Altman, 1991; Conti et al., 1997; Zhong et al.,
1997). Interestingly, REN expression was barely observed in
the layer of the ventricular zone lining the lumen, but was
instead confined to outer layers containing low proliferating
and newly differentiated neural cells. These in vivo observa-
tions are consistent with the in vitro findings that REN ex-
pression relates to growth arrest conditions in association
with neuronal differentiation. Indeed, NGF, RA, and serum
withdrawal, which inhibit neural cell proliferation (Screpanti
et al., 1992; Prinetti et al., 1997; Franklin et al., 1999; Bang
et al., 2001), increased REN expression in a number of cell
lines (e.g., N2a, PC12, and P19 cells) and enhanced neu-
ronal differentiation. The ability of REN to control cell
growth has been confirmed by REN-dependent inhibition of
proliferation in association with enhanced expression of cy-
clin D/cdk4 cell cycle inhibitor p27
Kip1 in P19 cells and in a
number of CNS- and PNS-derived cell lines. The require-
ment of REN for the RA-induced upregulation of ngn1 and
NeuroD expression, involved in neuronal differentiation of
P19 embryonal cells, is consistent with a previous report that
growth arrest and p27
Kip1 protein expression are enhanced by
these bHLH proteins (Farah et al., 2000).
These data are in agreement with previous reports which
describe that, after an initial burst of cell division during the
development of the mammalian embryonic nervous system,
the subsequent inhibition of cell proliferation is a prerequi-
site for neuronal differentiation (Mark and Storm, 1997).
Indeed, the combination of EGF with antiproliferative sig-
nals (e.g., cAMP) has been described to modify the mitoge-
nic properties of EGF and to convert it to a differentiation
factor (Mark and Storm, 1997). A number of reports suggest
that these negative regulatory signals might behave as a feed-
back loop which modulates the output of signals generated
by EGF itself. Indeed, developmental studies have provided
evidence that such a feed back regulation is required to en-
sure proper cell fate determination. For instance, Argos, an
inhibitor of Drosophila EGF-R (DER) function, is transcrip-
tionally triggered by DER itself, and specifies the patterning
of the ventral ectoderm in response to DER activity (Go-
lembo et al., 1996).
However, REN-induced growth inhibitory activity is not
sufficient to promote neuronal differentiation of all neural
progenitor cells, as suggested by its capacity to differentiate
neural committed ST14A and N2a cells, but not P19 pluri-
potent embryonal cells. Whether this is due to the ability of
REN to only partially recruit neuronal differentiation signals
in P19 cells, remains to be elucidated. However, the capacity
of REN to regulate ngn1 and NeuroD, but not Mash1 ex-
pression (Fig. 6), is consistent with this hypothesis. Accord-
ingly, Mash1 has been reported to be a much stronger in-
ducer of P19 cell neuronal differentiation, when compared
with ngn1 and NeuroD (Farah et al., 2000). Therefore,
whereas growth inhibitory activity appears to be a general
property of REN, its ability to promote neuronal differentia-
tion is restricted to neural committed CNS and PNS progen-
itors. REN requirement for RA-enhanced expression of ngn1
and  NeuroD but not of other HLH genes (e.g., Mash1,
Math1, Id1, and 3), suggests its involvement in specific regu-
latory pathways. This is further supported by the overlapping
patterns of expression of REN with ngn1 and NeuroD,
which were all detected in the ventral neural tube, in the ven-
tricular and adjacent intermediate zones of the cortex, and in
sensory ganglia (dorsal root ganglia and trigeminal ganglion)
in E8.5–E16 embryos (Sommer et al., 1996; Ma et al.,
1998). bHLH proteins have been implicated in the control
of the individual steps and the different cell lineages that
characterize the vertebrate CNS neurogenic process (Hassan
and Bellen, 2000). In the vertebrate PNS, neuronal lineage
development is initiated by the determination of multipotent
precursors via the action of neurogenins, with their function
being subsequently maintained by their target gene NeuroD.
Further lineage determination is specified by the action of in-
dependently regulated bHLH genes, such as Mash1 and
Math1 (Hassan and Bellen, 2000). The requirement of REN
for specific regulation of ngn1 and NeuroD expression but
not other bHLH genes (e.g., Mash1 and Math1) suggests an
influence upon early ngn1-dependent steps of neurogenesis,
via the regulation of specific bHLH proteins which influence
specific developmental phases or cell lineages. In conclusion,
we have identified a novel developmentally regulated gene
and its product, REN, that displays a neuroectodermal spe-
cific pattern of embryonal expression, promotes neural pro-
genitor cell growth arrest and neuronal differentiation. Such
features correlate with proliferative and differentiative status
of embryonic neuroepithelial cells in the murine forebrain.
These observations together with REN responsiveness to
distinct neurogenic stimuli (e.g., EGF, RA, and NGF) and
its involvement in the regulation of selected downstream sig-
nals (e.g., ngn1 and NeuroD), suggest a role in the transi-
tion from proliferation to differentiation of neural cells. In
particular, enhanced REN expression by mitogenic stimuli
such as EGF, may withdraw progenitor cells from the cell
cycle permitting their terminal neuronal differentiation.
Materials and methods
mRNA fingerprinting differential display, and REN 
Five 800–1,400-bp partially overlapping clones containing REN sequences
were obtained by screening an oligo(dT) and random primed Swiss Web-
ster/NIH mouse 7-d Embryo 5  Stretch Plus cDNA Library (CLONTECH
Laboratories, Inc.) with a 260-bp probe generated by mRNA fingerprinting
performed as described (Giannini et al., 2001). Full-length REN cDNA was
assembled from cloned sequences using AutoAssembler software (Perkin-
Elmer).
Plasmids
pCXN2-REN and pCXN2-REN-AS were obtained by cloning REN cDNA
fragment (1–2,015 bp) into the pCXN2 vector, provided by Dr. E.D. Adam-
son (Burnham Institute, La Jolla, CA) (Wu and Adamson, 1996), in sense
(pCXN2-REN) or antisense orientation (pCXN2-REN-AS). pCDNA/REN-
myc and pCXN2-REN-myc were constructed by cloning the coding region
of REN cDNA (737–1,438 nt) into pCDNA3.1( )/myc-His A and subse-
quently into pCXN2. Each clone was verified by automated DNA se-
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Production of anti-REN polyclonal antibody
Polyclonal antibodies against amino acid residues 116–232 of recombi-
nant GST–REN fusion protein were raised in New Zealand white male rab-
bit and purified using Sephadex Fast flow beads conjugated with a Protein
A (Sigma-Aldrich; Harlow and Lane, 1988).
Cell culture and transfections
TC-1S cells were cultured as described (Screpanti et al., 1992). P19 cells
were maintained in  MEM supplemented whith 7.5% heat-inactivated
newborn calf serum (GIBCO BRL) and 2.5% FCS. To induce differentia-
tion, 10
6 cells were allowed to aggregate in the presence of 1  M all trans-
RA (Sigma-Aldrich), and after 4 d embryoid bodies were dissociated and
transferred onto poly-L-lysine (Sigma-Aldrich) coated dishes without RA
and further treated with 4  M cytosine arabinoside after 24 h (Farah et al.,
2000). Differentiated neurons appeared after a further 24 h. PC12 cells
were grown on collagen-coated dishes in RPMI 1640 supplemented with
5% noninactivated FCS and 10% horse serum (Sigma-Aldrich).
ST14A embryonal CNS neural stem cells, provided by Dr. E. Cattaneo
(University of Milan, Milan, Italy), cultured at the permissive 33 C temper-
ature in 10% FCS growth medium, remained undifferentiated, whereas cell
division ceased and morphological differentiation occurred upon culture
at 33 C in serum-free conditioned medium, as described (Cattaneo and
Conti, 1998). N2a cells were maintained in DME supplemented with 10%
FCS and induced to differentiate by culturing in either 0.2% FCS (Franklin
et al., 1999) or 2% FCS plus 20  M RA (Prinetti et al., 1997). COS7 cells
were grown in DME with 10% FCS. Primary cultures of neural tube cells
were explanted from E9.5 mouse embryos in DME containing 10% FCS, as
described (Tajbakhsh et al., 1994).
Cells were transfected either with Lipofectamine (Life Technologies,
GIBCO BRL) or with Superfect Transfection Reagent (QIAGEN, Inc.). Poly-
clonal populations and individual clones of P19-pCXN2 and P19-REN-AS
cells, transfected with either pCXN2 vector or pCXN2-REN-AS, respec-
tively, were isolated by appropriate drug selection.
RNA analysis
RNA was isolated using either the RNeasy kit (QIAGEN, Inc.) or Trizol (Life
Technologies, GIBCO BRL), electrophoresed on a 6% formaldehyde/1%
agarose gel and blotted onto nylon membranes (Hybond-N, Amersham
Biosciences) for Northern analysis using 
32P labeled probes.
Semiquantitative RT-PCR was carried out on DNase Amp Grade
(GIBCO BRL)-treated RNA using MuLV RT (50 units) in 100 mM Tris-HCl,
pH 8.3, 500 mM KCl, 5 mM MgCl2, 0.5 mM each dNTP, 1 unit of Rnasin,
500 pmol of random hexamer primers. PCR cycles were designed to main-
tain the amplification in the exponential phase. RT-PCR products were
electrophoresed and hybridized to REN and GAPDH specific probes.
Primer sequences used for PCR were: REN sense primer 5 -GCTCTGACTG-
CAAGAGCATCGCCTC-3  and antisense primer 5 -AGACTTGCTAAGTTG-
GAGGCAGAGG-3 ; GAPDH sense primer 5 -CACCATGGAGAAGGC-
CGGGG-3  and antisense primer 5 -GACGGACACATTGGGGGTAG-3 ;
Id1 sense primer 5 -CCAGTGGCAGTGCCGCAGCCGCTGCAGGC-3  and
antisense primer 5 -GGCTGGAGTCCATCTGGTCCCTCAGTGC-3 ; Id3
sense primer 5 -AAGGCGCTGAGCCCGGTGC-3  and antisense primer 5 -
TCGGGAGGTGCCAGGACG-3 ; and ngn1 sense primer 5 -CCGACGA-
CACCAAGCTCA-3  and antisense primer 5 -GGGATGAAACAGGGCGTC-
3 . Probes for Math1, NeuroD and Mash1 were obtained from
CS2 MATH1, CS2p   NeuroD and CS2   Mash1 plasmids (Farah et al.,
2000), provided by Dr. D. Turner (University of Michigan, Ann Arbor, MI).
Immunofluorescence and confocal microscopy analysis
Immunofluorescence was performed on cells grown on 12-mm slides,
fixed for 10 min with 4% paraformaldehyde in PBS at room temperature,
and processed as previously described (Giannini et al., 2001). Primary an-
tibodies were: mouse monoclonal MAP2 and TuJ1 (MAB3418 and MAB
1637; Chemicon International, Inc.) and p27
Kip1 (K25020 Transduction
Laboratories); rabbit polyclonal anti-Myc Tag (06-549; Upstate Biotechnol-
ogy) and anti-GFP (sc-8334; Santa Cruz Biotechnology, Inc.). Secondary
antibodies were fluorescein- or Texas red–conjugated affinePure anti–rab-
bit or anti–mouse (Jackson ImmunoResearch Laboratories). Scanning con-
focal microscopy was performed using a laser scanning confocal micro-
scope Zeiss LSM, equipped with Argon and HeNe lasers.
Western blot analysis
Cell lysates were prepared in 20 mM Tris-HCl, pH 7.2, containing 8 M
urea, 140 mM  -Me, 0.1% SDS, and 20 mM EDTA, separated by 12%
SDS-PAGE and elettroblotted onto nitrocellulose membranes (Schleicher &
Schuell; Castellani et al., 1996). Immunoblotting was performed with
mouse monoclonal antibodies against either c-myc (9E10; Santa Cruz Bio-
technology, Inc.) or p27
Kip1 (K25020; Transduction Laboratories) or  -tubu-
lin (Ab1; Oncogene Science) or anti-REN polyclonal antibody; HRP-conju-
gated secondary Abs, anti–rabbit IgG and anti–mouse IgG (Santa Cruz
Biotechnology, Inc.) were used and immunoreactive bands visualized by
enhanced chemiluminescence (Pierce Chemical Co.).
Cell proliferation assay
Cell proliferation was evaluated by BrdU labeling and detection assay (Boeh-
ringer Mannheim GmbH), 24 h after transfection with test plasmids. The
cells were fixed after BrdU incorporation and permeabilized as described
above. After the primary and secondary labeling with anti-GFP or anti-Myc,
cells were refixed for 10 min with 4% paraformaldehyde in PBS at room
temperature, treated for 10 min with HCl 2N to denature DNA, and BrdU
detection was performed according to the manufacturer’s instructions.
RNA in situ hybridization
Embryos were prepared for whole-mount in situ hybridization as previ-
ously described (Tajbakhsh et al., 1998), modified with 16-h washes after
antibody incubation. mRNA transcripts were detected using Digoxigenin-
labeled 780-bp riboprobes containing 400 bp of the 3  coding region and
400 bp of 3  UTR of cDNA subcloned into pBluescript SK (Stratagene) and
synthetized using T3 or T7 polymerases. The probe used revealed repro-
ducible hybridization patterns when in antisense orientation and no signal
in the sense orientation (unpublished data). Photographs of whole-mount
stained embryos were taken with a Leica MZ8 stereomicroscope using
color reversal films (Ektachrome 64T). Stained embryos were embedded in
7% gelatin/15% sucrose and 30- m cryostate sections were cut. In situ hy-
bridization of post-embedded sections using the above described 
35S-
labeled REN probe was performed as described (Gulisano et al.,1996).
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